Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Shamol
    Junior Member
    • Sep 2016
    • 5

    #1

    Sample preparation and library information for HPV cervical swabs

    Hello all,

    My project involves sequencing the complete genomes of local Human Papillomavirus isolates. The isolates were collected from three kinds of samples:

    1. Tissue samples from cancer patients
    2. Cervical swabs from cancer patients
    3. Cervical swabs from asymptomatic HPV careers

    Most of the samples were of type 3 above. I have been trying to sequence some of these genomes using the PCR amplification followed by Sanger sequencing, but very, very few of the samples could be amplified to begin with (presumably because the DNA concentration especially in the swab samples were relatively low). My supervisor suggested I look into NGS as an alternative due to its high resolution.

    I'm from Bangladesh, and this technology is virtually unheard of here. I've been spending the past two weeks poring over papers on NGS and applications thereof in virology. I've picked up the general skeletal protocol, but there's only so much you can learn from papers and at some point you need directed expert advice. I'm currently looking for guidance on these three issues related sample preparation:

    1. Since the samples I'm working with contain host DNA, should I have a physical enrichment process (e.g. centrifugation and/or DNAse/RNAse treatment to remove unprotected nucleic acid) incorporated in the sample preparation?

    2. Given the low quantity of DNA in my samples, there's a chance that the amount of viral DNA would be very low. Is there a particularly high resolution library preparation service which can solve this problem? If so, what would be lowest quantity of DNA required?

    3. In the cancerous tissue samples (and cancerous cervical swabs), the HPV genome stays integrated into the host (human) genome, precluding the possibility of physical enrichment. How would the sample preparation work in this case?

    Thanks in advance for the replies, I'd appreciate them greatly.
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    Your problem is not the sequencing method; it's the inability to amplify your samples by PCR. NGS will not solve that problem, b/c it also requires PCR amplification of low abundance DNA samples. You need to troubleshoot the PCR protocol.

    Comment

    • Shamol
      Junior Member
      • Sep 2016
      • 5

      #3
      Thanks for your reply. Are you saying the problem I've been having with trying to amplify DNA with PCR (probably due to low quality of DNA in the original samples) will be there in an NGS platform as well? The whole reason I'm considering NGS is because my supervisor thought this could bypass the need for PCR, which has been really inconsistent with the samples we've been working with. Thanks again for the replies in advance.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:13 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Working...